| Date Filed | Type | Description |
| 10/03/2023 |
4
| SAHA SAURABH (CEO) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 36,263 shares
@ $6.47, valued at
$234.6k
|
|
| 07/03/2023 |
4
| SAHA SAURABH (CEO) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 36,263 shares
@ $5.9001, valued at
$214k
|
|
| 05/08/2023 |
4
| SAHA SAURABH (Director) has filed a Form 4 on CLARIVATE Plc|
Txns:
| Granted 22,058 shares
@ $0 |
|
| 05/08/2023 |
3
| SAHA SAURABH (Director) has filed a Form 3 on CLARIVATE Plc |
| 04/04/2023 |
4
| SAHA SAURABH (CEO) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 22,013 shares
@ $3.9, valued at
$85.9k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| SAHA SAURABH (CEO) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 44,025 shares
@ $3.1, valued at
$136.5k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2021 |
4
| SAHA SAURABH (CEO) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Bought 23,000 shares
@ $12.2814, valued at
$282.5k
|
|
| 05/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |